Ondine Biomedical Inc (OBI.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,049 | 1,203 | 638 | 2,569 | 1,791 |
| Cost of Goods | 728 | 500 | 351 | 1,315 | 1,142 |
| Gross Profit | 1,321 | 703 | 287 | 1,254 | 649 |
| Operating Expenses | 20,765 | 15,508 | 19,050 | 18,774 | 16,520 |
| Operating Income | -19,444 | -14,805 | -18,763 | -17,520 | -15,871 |
| Interest Expense | 47 | 38 | 30 | 1,199 | 491 |
| Other Income | 393 | 431 | -579 | -31,366 | 155 |
| Pre-tax Income | -19,098 | -14,412 | -19,372 | -50,085 | -16,207 |
| Net Income Continuous | -19,098 | -14,412 | -19,372 | -50,085 | -16,207 |
| Minority Interests | N/A | N/A | N/A | N/A | 2 |
| Net Income | $-19,098 | $-14,412 | $-19,372 | $-50,085 | $-16,205 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.10 | -0.63 | -0.08 |
| EPS Basic Continuous Ops | -0.07 | -0.07 | -0.10 | -0.63 | -0.08 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.10 | -0.63 | -0.08 |
| EPS Diluted Continuous Ops | -0.07 | -0.07 | -0.10 | -0.63 | -0.08 |
| EBITDA(a) | $-18,486 | $-13,787 | $-18,849 | $-48,372 | $-14,496 |